Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 12/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAF1 | P04049 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2278422 | 0.91 | ABL1 (0.36) | ABL1GAARAB9AKDM4EMEN1 | |
| SCHEMBL14642988 | 0.89 | ABL1 (0.33) | ABL1GAAKDM4E | |
| SCHEMBL2277051 | 0.87 | ABL1 (0.33) | ABL1 | |
| SCHEMBL20806159 | 0.86 | RAB9A (0.41) | ABL1RAB9AMEN1MAPTKMT2A | |
| SCHEMBL2169876 | 0.86 | CHEK1 (0.41) | ABL1GAARAB9AKDM4EMEN1 | |
| SCHEMBL2152686 | 0.86 | POLB (0.41) | ABL1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL12374481 | 0.85 | KDM4E (0.31) | ABL1GAARAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL12462223 | 0.85 | ABL1 (0.38) | ABL1GAARAB9AKDM4EMEN1 | |
| SCHEMBL12374484 | 0.85 | LMNA (0.37) | ABL1GAARAB9AKDM4EMEN1 | |
| SCHEMBL12374480 | 0.85 | KDM4E (0.33) | ABL1GAARAB9AKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2021-10-12 | — | — | US | disclosed |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2020-10-27 | — | — | US | disclosed |
| EP-2521530-B1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | OREAL (FR) | 2019-06-26 | — | — | EP | disclosed |
| US-8575341-B2 | Cosmetic composition, cosmetic treatment method, and compound | L'OREAL (FR) | 2013-11-05 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| US-20110189118-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | L'OREAL (FR) | 2011-08-04 | — | — | US | disclosed |
| WO-2011083243-A1 | COSMETIC TREATMENT METHODS AND KIT | L'OREAL (FR) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011080494-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2011-07-07 | — | — | WO | disclosed |
| WO-2010001041-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | L'OREAL (FR) | 2010-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | KRT18, KIT, TYR | ABL1 1039/4885GAA 2948/4885RAB9A 4019/4885 |
| US-20110189118-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | KRT18, MC1R, C1R | ABL1 4705/4885GAA 4592/4885RAB9A 2890/4885 |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | ABL1 1039/4885GAA 2948/4885RAB9A 4019/4885 |
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | ABL1 1039/4885GAA 2948/4885RAB9A 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.